The ursodeoxycholic acid story in primary biliary cirrhosis.
Open Access
- 1 September 1995
- Vol. 37 (3), 301-304
- https://doi.org/10.1136/gut.37.3.301
Abstract
No abstract availableThis publication has 58 references indexed in Scilit:
- Soluble E-selectin and vascular cell adhesion molecule-1 (VCAM-1) in primary biliary cirrhosisJournal of Hepatology, 1995
- Soluble intercellular adhesion molecule-1 in primary biliary cirrhosis: Relationship with disease stage, immune activity and cholestasisHepatology, 1994
- The canadian multicenter double-blind randomized controlled trial of ursodeoxycholic acid in primary biliary cirrhosisHepatology, 1994
- Different response to ursodeoxycholic acid (UDCA) in primary biliary cirrhosis according to severity of diseaseDigestive Diseases and Sciences, 1994
- Immunomodulating effect of ursodeoxycholic acid therapy in patients with primary biliary cirrhosisJournal of Hepatology, 1993
- Ursodeoxycholic acid administration on bile acid metabolism in patients with early stages of primary biliary cirrhosisDigestive Diseases and Sciences, 1993
- Conjugates of ursodeoxycholate protect against cytotoxicity of more hydrophobic bile salts:In vitro studies in rat hepatocytes and human erythrocytesHepatology, 1991
- Ursodeoxycholic acid in chronic liver disease.Gut, 1991
- Ursodeoxycholic acid in primary biliary cirrhosis: no evidence for toxicity in the stages I to IIIJournal of Hepatology, 1990
- Gallstone dissolution with ursodeoxycholic acid in patients with chronic active hepatitis and two years follow-upDigestive Diseases and Sciences, 1985